Rankings
▼
Calendar
DBVT FY 2023 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena
DBVT
DBV Technologies S.A.
$560M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
+227.7% YoY
Gross Profit
$16M
100.0% margin
Operating Income
-$76M
-486.0% margin
Net Income
-$73M
-462.4% margin
EPS (Diluted)
$-3.80
Cash Flow
Operating Cash Flow
-$80M
Free Cash Flow
-$80M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$183M
Total Liabilities
$43M
Stockholders' Equity
$140M
Cash & Equivalents
$141M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$5M
+227.7%
Gross Profit
$16M
-$15M
+201.5%
Operating Income
-$76M
-$97M
+20.9%
Net Income
-$73M
-$96M
+24.5%
← Q4 2022
All Quarters
Q1 2023 →